1. Market Research
  2. > Crucell N.V. - Strategic SWOT Analysis Review

Crucell N.V. - Strategic SWOT Analysis Review

  • February 2015
  • -
  • Global Data
  • -
  • 27 pages

Crucell N.V. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services.

This up-to-the-minute company report will help you to formulate strategies to drive your business by enabling you to understand your partners, customers and competitors better.

Scope

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – GlobalData’s summarization of the company’s business strategy.
- SWOT analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list of key locations and subsidiaries of the company, including contact details.
- Key manufacturing facilities – A list of key manufacturing facilities of the company.

Highlights

Crucell N.V. (Crucell) is a biopharmaceutical company. It discovers, develops, manufactures and markets vaccines and antibodies indicated against infectious diseases. Its product portfolio comprises marketed products, vaccines under development and development stage antibodies. The company’s range of marketed vaccine is targeted towards paediatric, respiratory and travel or endemic infections. Its research and development pipeline consists of vaccines evaluated for treatment against ebola and marburg, HIV, cell based influenza, universal influenza, human papilloma virus (HPV) and respiratory syncytial virus (RSV). The company's products are developed using its proprietary technology platforms. It has operations in China, the Netherlands, Switzerland, Italy, Spain, the UK, Korea, Sweden and the US. Crucell is a part of Janssen Pharmaceutical Companies, a subsidiary of Johnson & Johnson and is headquartered in Leiden, the Netherlands.

Reasons to Buy

- Gain key insights into the company for academic or business research purposes. Key elements such as SWOT analysis and corporate strategy are incorporated in the profile to assist your academic or business research needs.
- Identify potential customers and suppliers with this report’s analysis of the company’s business structure, operations, major products and services and business strategy.
- Understand and respond to your competitors’ business structure and strategies with GlobalData’s detailed SWOT analysis. In this, the company’s core strengths, weaknesses, opportunities and threats are analyzed, providing you with an up to date objective view of the company.
- Examine potential investment and acquisition targets with this report’s detailed insight into the company’s strategic, business and operational performance.

Note: Some sections may be missing if data is unavailable for the company.

Table Of Contents

Crucell N.V. - Strategic SWOT Analysis Review
Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 4
Section 1 - About the Company 5
Crucell N.V. - Key Facts 5
Crucell N.V. - Key Employees 6
Crucell N.V. - Major Products and Services 7
Crucell N.V. - Pharmaceutical Pipeline Products Data 8
Crucell N.V., Pipeline Products by Therapy Area 8
Crucell N.V., Pipeline Products by Development Phase 9
Crucell N.V. - History 11
Crucell N.V. - Company Statement 14
Crucell N.V. - Locations And Subsidiaries 15
Head Office 15
Other Locations and Subsidiaries 15
Section 2 - Company Analysis 17
Crucell N.V. - Business Description 17
Crucell N.V. - Corporate Strategy 18
Crucell N.V. - SWOT Analysis 19
SWOT Analysis - Overview 19
Crucell N.V. - Strengths 19
Strength - Focused Research Activities 19
Strength - Global Presence 19
Strength - Proprietary and Novel Technology Platforms 19
Crucell N.V. - Weaknesses 20
Weakness - Limited Number of Products and Customers 20
Crucell N.V. - Opportunities 21
Opportunity - Growing Incidence of Infectious Diseases 21
Opportunity - Promising Product Pipeline 21
Opportunity - Strategic Partnerships 21
Crucell N.V. - Threats 22
Threat - Intense Competition 22
Threat - Government Regulations 22
Threat - Uncertain RandD Outcomes 22
Crucell N.V. - Key Competitors 23
Section 3 - Company's Lifesciences Financial Deals and Alliances 24
Crucell N.V., Pharmaceuticals and Healthcare, Deals By Year, 2009 to YTD 2015 24
Crucell N.V., Pharmaceuticals and Healthcare, Deals By Type, 2009 to YTD 2015 25
Crucell N.V., Recent Deals Summary 26
Section 4 - Appendix 27
Methodology 27
About GlobalData 27
Contact Us 27
Disclaimer 27

List of Tables

Crucell N.V., Key Facts 5
Crucell N.V., Key Employees 6
Crucell N.V., Major Products and Services 7
Crucell N.V., Number of Pipeline Products by Therapy Area 8
Crucell N.V., Number of Pipeline Products by Development Stage 9
Crucell N.V., Pipeline Products By Therapy Area and Development Phase 10
Crucell N.V., History 11
Crucell N.V., Other Locations 15
Crucell N.V., Subsidiaries 15
Crucell N.V., Key Competitors 23
Crucell N.V., Pharmaceuticals and Healthcare, Deals By Year, 2009 to YTD 2015 24
Crucell N.V., Pharmaceuticals and Healthcare, Deals By Type, 2009 to YTD 2015 25
Crucell N.V., Recent Deals Summary 26

List of Figures

Crucell N.V., Pipeline Products by Therapy Area 8
Crucell N.V., Pipeline Products by Development Phase 9
Crucell N.V., Pharmaceuticals and Healthcare, Deals By Year, 2009 to YTD 2015 24
Crucell N.V., Pharmaceuticals and Healthcare, Deals by Type, 2009 to YTD 2015 25

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Amrita

+1 718 303 2019

ref:plp2015

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.